ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Conference Level For NCI Is 5.4% Over FY 1990

November 2, 1990

Fellowships In Japan Available Through NIH

October 13, 1995

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

NCAB Jolted By 1977 Prelim Budget, “Outrageous” Prospect – Funding Only 30% Of Approved Grants

June 27, 1975

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006